KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Times Interest Earned (2017 - 2025)

Aquestive Therapeutics has reported Times Interest Earned over the past 9 years, most recently at -$10.38 for Q4 2025.

  • Quarterly results put Times Interest Earned at -$10.38 for Q4 2025, down 112.46% from a year ago — trailing twelve months through Dec 2025 was -$6.39 (down 130.94% YoY), and the annual figure for FY2025 was -$6.39, down 130.94%.
  • Times Interest Earned for Q4 2025 was -$10.38 at Aquestive Therapeutics, down from -$4.13 in the prior quarter.
  • Over the last five years, Times Interest Earned for AQST hit a ceiling of $0.02 in Q2 2024 and a floor of -$10.38 in Q4 2025.
  • Median Times Interest Earned over the past 5 years was -$3.65 (2024), compared with a mean of -$4.36.
  • Biggest five-year swings in Times Interest Earned: surged 100.65% in 2024 and later crashed 20754.23% in 2025.
  • Aquestive Therapeutics' Times Interest Earned stood at -$6.69 in 2021, then rose by 2.96% to -$6.49 in 2022, then skyrocketed by 73.5% to -$1.72 in 2023, then crashed by 183.98% to -$4.89 in 2024, then tumbled by 112.46% to -$10.38 in 2025.
  • The last three reported values for Times Interest Earned were -$10.38 (Q4 2025), -$4.13 (Q3 2025), and -$4.09 (Q2 2025) per Business Quant data.